Jext (Epinephrine Bitartrate)

Epinephrine acts as a non‑selective agonist at alpha and beta adrenergic receptors. Stimulation of alpha‑1 receptors causes vasoconstriction, raising systemic vascular resistance; beta‑1 activation increases heart rate and contractility, boosting cardiac output; beta‑2 activation relaxes bronchial smooth muscle, producing bronchodilation.

The exact dose of Jext is determined by the prescribing clinician based on the patient’s age, weight, and severity of the reaction. In many adult emergency protocols, a 0.3 mg intramuscular dose is common, but the prescriber sets the final regimen.

Safety data for epinephrine during pregnancy and lactation are limited. It should be used only if the potential benefit outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Jext, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request trade or institutional credentials before providing pricing, availability, shipping details (including cold‑chain if needed) and import documentation.

Jext provides epinephrine in a standard injectable solution for intramuscular use, similar in pharmacology to auto‑injector devices and other ampoules. Differences lie mainly in formulation, packaging, and regulatory status; the clinical effect is comparable when administered correctly.

Jext must be stored at 2‑8 °C, protected from light, and kept in its original container. It should not be frozen or shaken. If the product reaches room temperature, it may be used for a limited period as indicated by the manufacturer, but refrigeration should be restored promptly.

Jext is given as a single intramuscular injection, typically into the mid‑outer thigh (vastus lateralis). Administration should be performed by trained personnel using aseptic technique, and the patient should be monitored closely for therapeutic response and adverse reactions.

Serious risks include severe hypertension, cardiac arrhythmias, myocardial ischemia, and pulmonary edema. These events are rare but require immediate medical attention. Continuous monitoring of blood pressure and cardiac rhythm after administration is essential, especially in patients with pre‑existing cardiovascular disease.

Jext is contraindicated in individuals with known hypersensitivity to epinephrine or any of its excipients. Caution is advised for patients with certain cardiovascular conditions such as uncontrolled hypertension, severe coronary artery disease, or ventricular arrhythmias, and it should only be used under medical supervision.